学术周报 · IF≥10

骨科领域文献阅读汇编

2026年第39周 (2026-09-23) | PubMed (NLM) · DeepSeek 中英双语
数据来源: PubMed E-utilities · 影响因子筛选≥10 · 完整摘要不截断
收录论文
13
临床研究
4
基础研究
9
IF≥20
2
IF 10-20
11
子领域
8
期刊种类
9
数据日期
2026-09-23

★本周 Top 10 高影响力文献

#论文期刊IF
1Fracture healing: from molecular and cellular mechanisms to therapeutic strategies.Signal transduction and targeted therapyIF 81.2
2A liver-cartilage selenium axis underlies metabolic comorbidity in osteoarthritis.Cell metabolismIF 37.0
3High-impact physical activity participation and 12-month risk of joint replacement: a longitudinal m...British journal of sports medicineIF 15.5
4GLP-1 receptor agonists and weight-loss strategies for individuals with obesity and hip or knee oste...British journal of sports medicineIF 15.5
5Longitudinal cohort study of the association between labral pathology and cartilage loss in high-imp...British journal of sports medicineIF 15.5
6Digital therapeutic combining exercise and cognitive-behavioural therapy reduces pain in patients wi...British journal of sports medicineIF 15.5
7Targeting the gut-bone axis in osteoporosis: probiotic interventions and other microbiota-based ther...Gut microbesIF 15.3
8Ciliary Ift20 and Wwtr1 Coordinate Transforming Growth Factor-β Receptor II Signaling to Maintain Bo...MedCommIF 14.1
9Osteomyelitis: Epidemiology, Classification, Pathophysiology, Clinical Features, Diagnosis, and Mana...MedCommIF 14.1
10Kaempferol attenuates type 2 diabetic osteoporosis via METTL3/YTHDF2-regulated PTEN m⁶A methylation ...Pharmacological researchIF 12.2

Ŧ期刊分布统计

期刊篇数IF
British journal of sports medicine4IF 15.5
MedComm2IF 14.1
Gut microbes1IF 15.3
Cell metabolism1IF 37.0
ACS sensors1IF 10.9
Signal transduction and targeted therapy1IF 81.2
Materials horizons1IF 11.4
Acta biomaterialia1IF 10.4
Pharmacological research1IF 12.2

1骨质疏松/骨代谢 (3篇)

基础研究 (3篇)

Gut microbes IF 15.3 2026-9-18 PMID: 42755181
Osteoporosis (OP) is a systemic bone metabolic disorder characterized by impaired bone homeostasis and increased fracture susceptibility. With the rapid aging of the global population, the number of fractures related to osteoporosis continues to increase, along with persistently high rates of disability and mortality, thereby imposing a huge and constantly growing burden on the healthcare system. Emerging evidence indicates that probiotics, as key regulators of host metabolic and immune networks, play critical roles in the pathogenesis, progression, and therapeutic modulation of OP. Through a bidirectional regulatory network known as the gut-bone axis, probiotics influence the dynamic balance between bone formation and bone resorption via multiple interconnected mechanisms, including immune modulation, microbial metabolite production, intestinal barrier integrity, and endocrine signaling. Recent animal and clinical studies further demonstrate that targeted modulation of the gut microbiota to restore gut-bone axis homeostasis can significantly improve bone mineral density and related skeletal parameters, highlighting the translational potential of probiotic-based interventions. This review systematically summarizes the molecular mechanisms by which probiotics regulate bone metabolism and places particular emphasis on emerging microbiota-based mechanisms and therapeutic strategies, with a specific focus on probiotics, aiming to provide a theoretical framework and future translational directions for the development of innovative microbiota-based treatments for OP.
中文摘要:骨质疏松症(OP)是一种系统性骨代谢紊乱,以骨稳态受损和骨折易感性增加为特征。随着全球人口快速老龄化,与骨质疏松相关的骨折数量持续增加,且致残率和死亡率长期居高不下,从而给医疗系统带来巨大且不断增长的负担。新出现的证据表明,益生菌作为宿主代谢和免疫网络的关键调节因子,在OP的发病、进展和治疗调控中发挥重要作用。通过被称为肠-骨轴的双向调控网络,益生菌经多种相互关联的机制影响骨形成与骨吸收之间的动态平衡,包括免疫调节、微生物代谢产物生成、肠道屏障完整性和内分泌信号传导。近期动物和临床研究进一步表明,靶向调节肠道菌群以恢复肠-骨轴稳态,可显著改善骨密度及相关骨骼参数,凸显了基于益生菌干预的转化潜力。本综述系统总结了益生菌调控骨代谢的分子机制,并特别强调新兴的基于微生物群的机制和治疗策略,重点关注益生菌,旨在为开发创新性基于微生物群的OP治疗提供理论框架和未来转化方向。
MedComm IF 14.1 2026-9-22 PMID: 42769548
The balance between bone formation and bone marrow adipose tissue accumulation is essential for skeletal integrity, and disruption of this balance contributes to skeletal degeneration, osteoporosis, and metabolic bone loss. However, the molecular mechanisms controlling this balance across skeletal homeostasis and disease remain unclear. Here, transcriptomic analysis of human osteoporotic bone samples revealed significant downregulation of Ift20 and Wwtr1 in osteoblast-lineage cells. Using osteoblast-specific knockout models, we found that loss of both Ift20 and Wwtr1 in the osteoblast lineage caused severe bone loss and excessive bone marrow adipose tissue accumulation, which was further aggravated under ovariectomy and high-fat diet conditions. Mechanistically, Ift20 localized to primary cilia and interacted with transforming growth factor-β receptor II (TβRII), protecting it from c-Cbl-mediated ubiquitination and degradation to sustain TGF-β signaling. Meanwhile, Wwtr1 directly bound the TβRII promoter to promote its transcription. Loss of Ift20 and Wwtr1 converged on TβRII suppression, impairing osteoblast differentiation while enhancing adipogenesis and osteoclastogenesis. These findings reveal a previously unrecognized cilia-transcription-TGF-β regulatory mechanism that governs osteoblast-adipocyte fate decisions and skeletal remodeling. The Ift20-Wwtr1-TβRII axis represents a critical safeguard of bone mass and marrow fat balance and may provide a therapeutic target for osteoporosis and metabolic bone diseases.
中文摘要:骨形成与骨髓脂肪组织积累之间的平衡对骨骼完整性至关重要,这种平衡的破坏会导致骨骼退变、骨质疏松和代谢性骨丢失。然而,在骨骼稳态和疾病中控制这一平衡的分子机制仍不清楚。在此,对人骨质疏松骨样本的转录组分析显示,成骨细胞谱系细胞中Ift20和Wwtr1显著下调。利用成骨细胞特异性敲除模型,我们发现成骨细胞谱系中Ift20和Wwtr1的缺失会导致严重骨丢失和骨髓脂肪组织过度积累,并且在卵巢切除和高脂饮食条件下进一步加重。机制上,Ift20定位于初级纤毛,并与转化生长因子-β受体II(TβRII)相互作用,保护其免受c-Cbl介导的泛素化和降解,从而维持TGF-β信号传导。同时,Wwtr1直接结合TβRII启动子以促进其转录。Ift20和Wwtr1的缺失共同导致TβRII抑制,损害成骨细胞分化,同时增强脂肪生成和破骨细胞生成。这些发现揭示了一种此前未被认识的纤毛-转录-TGF-β调控机制,该机制调控成骨细胞-脂肪细胞命运决定和骨骼重塑。Ift20-Wwtr1-TβRII轴是骨量和骨髓脂肪平衡的关键保障,并可能为骨质疏松和代谢性骨病提供治疗靶点。
Pharmacological research IF 12.2 2026-9-18 PMID: 42759588
Type 2 diabetic osteoporosis (T2DOP) features impaired bone quality and high fracture risk, with unclear pathogenesis and limited targeted therapies. This study explored the therapeutic effect and molecular mechanism of kaempferol against T2DOP via m⁶A modification and ferritinophagy-dependent ferroptosis using bioinformatic, cellular and animal approaches. We analyzed the single-cell RNA-seq dataset GSE212726, and predicted core targets of kaempferol through network pharmacology and molecular docking. A high-glucose-high-fat (HGHF)-induced T2DOP cellular model and streptozotocin plus high-fat diet-induced mouse T2DOP model were established for functional verification with multiple molecular assays and DC-Y13-27 (a selective YTHDF2 antagonist) rescue experiments. We found ferritinophagy and ferroptosis were highly activated in T2DOP-derived BMSCs. HGHF triggered ferroptosis, disrupted BMSC functions and osteogenic-adipogenic balance, which was rescued by kaempferol. Mechanistically, kaempferol elevates METTL3 expression to promote m⁶A modification of PTEN mRNA. Subsequent recognition of methylated PTEN by YTHDF2 accelerates PTEN degradation, which further activates PI3K/AKT signaling and ultimately suppresses ferritinophagy-triggered ferroptosis. In vivo, kaempferol alleviated bone microstructure deterioration in T2DOP mice, while DC-Y13-27 reversed these protective effects. In summary, kaempferol alleviates T2DOP by suppressing ferritinophagy-dependent ferroptosis via the METTL3/YTHDF2/PTEN/PI3K/AKT axis, offering a promising therapeutic candidate for T2DOP.
中文摘要:2型糖尿病骨质疏松症(T2DOP)以骨质量受损和高骨折风险为特征,其发病机制尚不清楚且靶向治疗有限。本研究通过生物信息学、细胞和动物方法,探讨山柰酚经m⁶A修饰及铁蛋白自噬依赖性铁死亡对T2DOP的治疗作用和分子机制。我们分析了单细胞RNA测序数据集GSE212726,并通过网络药理学和分子对接预测山柰酚的核心靶点。建立高糖高脂(HGHF)诱导的T2DOP细胞模型和链脲佐菌素联合高脂饮食诱导的小鼠T2DOP模型,利用多种分子实验和DC-Y13-27(一种选择性YTHDF2拮抗剂)挽救实验进行功能验证。我们发现铁蛋白自噬和铁死亡在T2DOP来源的BMSCs中高度激活。HGHF触发铁死亡,破坏BMSC功能及成骨-成脂平衡,而山柰酚可挽救这些改变。机制上,山柰酚升高METTL3表达,促进PTEN mRNA的m⁶A修饰。随后YTHDF2识别甲基化PTEN,加速PTEN降解,进一步激活PI3K/AKT信号,最终抑制铁蛋白自噬触发的铁死亡。在体内,山柰酚减轻T2DOP小鼠的骨微结构恶化,而DC-Y13-27逆转这些保护作用。总之,山柰酚通过METTL3/YTHDF2/PTEN/PI3K/AKT轴抑制铁蛋白自噬依赖性铁死亡,从而缓解T2DOP,为T2DOP提供了一种有前景的治疗候选药物。

2生物材料/植入物 (3篇)

基础研究 (3篇)

ACS sensors IF 10.9 2026-9-22 PMID: 42771020
Deep eutectic solvent (DES)-based gels combine low volatility with ionic conductivity for soft sensing, but balancing mechanical compliance, interfacial adhesion, and ion transport remains challenging. Here, a post-formation solvent-exchange strategy is employed to reconstruct a physically crosslinked poly(vinyl alcohol) (PVA) network using a Fe3+-containing DES. Spectroscopic, structural, and computational analyses reveal a reconstructed interaction environment in which hydrogen bonding coexists with Fe3+-mediated interactions, accompanied by extensive disruption of ordered PVA chain packing. The resulting UFP eutectogel exhibits a tensile strength of 0.43 MPa, a fracture strain of 423%, a toughness of 0.62 MJ·m-3, and an ionic conductivity of 0.42 S·m-1, together with reversible multisubstrate adhesion and improved resistance to solvent loss. UFP supports independently configured strain and pressure sensing and can be integrated into a 3 × 3 array for spatial pressure-pattern mapping. An encapsulated plantar sensor further generates distinguishable resistance waveforms for four simulated gait patterns, enabling proof-of-concept pattern classification using a neural-network model. These results demonstrate post-formation solvent exchange as an effective approach for regulating the balance among mechanical compliance, ionic transport, adhesion, and sensing functionality in PVA-based eutectogels.
中文摘要:深共晶溶剂(DES)基凝胶兼具低挥发性和离子导电性,可用于柔性传感,但平衡力学顺应性、界面黏附与离子传输仍具挑战。本文采用形成后溶剂交换策略,利用含Fe3+的DES重构物理交联的聚乙烯醇(PVA)网络。光谱、结构和计算分析揭示了重构的相互作用环境,其中氢键与Fe3+介导的相互作用共存,同时PVA链的有序堆积被广泛破坏。所得UFP共晶凝胶表现出0.43 MPa的拉伸强度、423%的断裂应变、0.62 MJ·m-3的韧性和0.42 S·m-1的离子电导率,并具有可逆的多基底黏附以及改善的抗溶剂损失能力。UFP可支持独立配置的应变和压力传感,并能集成到3 × 3阵列中用于空间压力模式映射。一个封装式足底传感器进一步为四种模拟步态模式生成可区分的电阻波形,从而能够使用神经网络模型进行概念验证性模式分类。这些结果表明,形成后溶剂交换是调控PVA基共晶凝胶中力学顺应性、离子传输、黏附与传感功能之间平衡的有效方法。
Materials horizons IF 11.4 2026-8-5 PMID: 42552935
Tough adhesives require efficient bulk energy dissipation, yet the molecular design principles for achieving this without sacrificing adhesion strength remain a challenge. Here, we report a chain-length regulation strategy for UV-curable acrylate adhesives, in which long polymer strands between cross-linking points generate effective entanglements, thereby promoting bulk energy dissipation during debonding. The resulting adhesives achieve exceptional adhesion strength (23.13 MPa) and ultrahigh adhesion toughness (36.77 kJ m-2). Fracture measurements and digital image correlation show that the long-chain entangled network markedly increases bulk fracture energy by delocalizing crack-tip strain into an enlarged deformation process zone and retarding crack propagation. Chain-dynamics and chain-conformation analyses further confirm the role of entanglement by revealing a broader relaxation spectrum and a much larger releasable conformational length in the long-chain network that enhances bulk energy dissipation. We further demonstrate its application potential and excellent long-term environmental stability, together with a physics-informed prediction of long-term adhesion retention across practical service temperatures. These results establish chain-length regulation as an effective molecular design strategy for strong and tough adhesives.
中文摘要:坚韧胶粘剂需要有效的本体能量耗散,然而在不牺牲粘附强度的前提下实现这一点的分子设计原则仍是一项挑战。在此,我们报道了一种用于紫外固化丙烯酸酯胶粘剂的链长调控策略,其中交联点之间的长聚合物链段产生有效缠结,从而在脱粘过程中促进本体能量耗散。所得胶粘剂实现了优异的粘附强度(23.13 MPa)和超高粘附韧性(36.77 kJ m-2)。断裂测量和数字图像相关表明,长链缠结网络通过将裂纹尖端应变离域到扩大的形变过程区并延缓裂纹扩展,显著提高了本体断裂能。链动力学和链构象分析进一步证实了缠结的作用,揭示出长链网络具有更宽的松弛谱和更大的可释放构象长度,从而增强本体能量耗散。我们进一步展示了其应用潜力与优异的长期环境稳定性,并结合物理信息模型预测了在实际使用温度范围内的长期粘附保持率。这些结果确立了链长调控作为一种有效分子设计策略,用于制备强而韧的胶粘剂。
Acta biomaterialia IF 10.4 2026-9-19 PMID: 42762844
Polyvinyl alcohol (PVA) is a synthetic polymer that is increasingly being used in biomedical applications due to its biocompatibility, aqueous solubility, low toxicity, and tissue-mimicking properties. The physiochemical properties of PVA hydrogels are widely tunable and allow for a diverse range of tissue-specific applications and delivery methods. In this review, we evaluate the published information on the history of PVA with respect to its safety and efficacy as a biomedical device for orthopedic applications in articular cartilage, fibrocartilage, and intervertebral disc prosthesis. The review includes a classification of the mechanical properties, swelling mechanics, and lubricity and wear properties of the use of PVA in clinical applications, and in vitro and in vivo biocompatibility studies. STATEMENT OF SIGNIFICANCE: This review synthesizes the engineering design principles that underpin the development of poly(vinyl alcohol) (PVA) hydrogels for orthopedic applications, including articular cartilage, fibrocartilaginous tissues, and intervertebral disc repair and replacement. By critically examining how molecular characteristics, crosslinking strategies, processing methods, composite architectures, and biomimetic designs influence mechanical performance, tribological behavior, swelling regulation, fatigue resistance, and biocompatibility, the review establishes a framework linking material design decisions to functional outcomes. Unlike prior reviews focused primarily on individual tissues or material formulations, this work emphasizes the translational pathway through which these design principles have been leveraged to progress from benchtop materials development to preclinical validation, clinical evaluation, and commercial orthopedic products. By identifying both successful strategies and persistent translational challenges, this review provides practical guidance for biomaterials scientists and orthopedic researchers developing the next generation of load-bearing hydrogel implants.
中文摘要:聚乙烯醇(PVA)是一种合成聚合物,由于其生物相容性、水溶性、低毒性以及模拟组织的特性,正越来越多地用于生物医学应用。PVA水凝胶的理化性质具有广泛的可调性,可实现多种组织特异性应用和递送方式。在本综述中,我们评估了已发表的信息,涉及PVA的历史,以及其作为骨科应用生物医学装置在关节软骨、纤维软骨和椎间盘假体中的安全性和有效性。本综述包括对PVA在临床应用中使用的机械性能、溶胀力学、润滑性和磨损性能的分类,以及体外和体内生物相容性研究。意义声明:本综述综合了支撑用于骨科应用的聚乙烯醇(PVA)水凝胶开发的工程设计原则,包括关节软骨、纤维软骨组织和椎间盘修复与置换。通过批判性审视分子特征、交联策略、加工方法、复合结构以及仿生设计如何影响机械性能、摩擦学行为、溶胀调控、抗疲劳性和生物相容性,本综述建立了一个将材料设计决策与功能结果联系起来的框架。与先前主要关注单个组织或材料配方的综述不同,本工作强调了这些设计原则已被用于从台式材料开发推进到临床前验证、临床评价和商业骨科产品的转化路径。通过识别成功策略和持续存在的转化挑战,本综述为开发下一代承重水凝胶植入物的生物材料科学家和骨科研究人员提供了实用指导。

3骨关节炎/软骨 (2篇)

临床研究 (1篇)

British journal of sports medicine IF 15.5 2026-6-20 PMID: 42321007
To map current strategies for weight loss in hip and knee osteoarthritis (OA), with emphasis on the emerging role of glucagon-like peptide-1 receptor agonists (GLP-1-RAs) as tools in achieving weight loss and impacting symptoms, disease progression and perioperative outcomes in individuals with obesity. Scoping review conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) framework and methodological guidance from the Joanna Briggs Institute and Arksey and O'Malley. PubMed, Web of Science, Directory of Open Access Journals, Scopus, ProQuest Central (1 January 2010 to 18 August 2025). Included studies focused on adults (≥18 years) with obesity and hip or knee OA, examined weight-loss strategies (nutritional, physical activity, surgical or pharmacological) including GLP-1-RAs. Of 199 included studies, 36 (18.1%) directly assessed GLP-1-RAs and of these, 14/36 (38.9%) reported original data. Evidence was heavily skewed towards knee OA, with limited hip-specific data. Descriptive analysis revealed a narrow geographical distribution of studies and a rapidly increasing focus on GLP-1-RAs; most studies involving GLP-1-RAs (29/36, 80.6%) were published between 2024 and 2025 and were of a low level of evidence (19/36, 52.8% level 5). Randomised and cohort data in knee OA indicate that GLP-1-RAs are associated with substantial weight loss, with accompanying improvements in pain/function and reduced progression to arthroplasty. In contrast, evidence in hip OA is sparse with weaker associations. GLP-1-RAs represent a promising adjunct for managing individuals with OA complicated by obesity. Until further evidence emerges, GLP-1-RAs should be integrated into supervised, multimodal musculoskeletal care rather than used as standalone weight-loss agents.
中文摘要:旨在梳理髋和膝骨关节炎(OA)患者当前的减重策略,重点关注胰高血糖素样肽-1受体激动剂(GLP-1-RAs)作为减重工具的新兴作用,及其对肥胖个体症状、疾病进展和围手术期结局的影响。按照系统综述和荟萃分析优先报告条目范围综述扩展版(PRISMA-ScR)框架以及乔安娜布里格斯研究所和Arksey与O'Malley的方法学指导开展范围综述。检索PubMed、Web of Science、开放获取期刊目录、Scopus、ProQuest Central(2010年1月1日至2025年8月18日)。纳入研究聚焦于年龄≥18岁、患有肥胖和髋或膝OA的成人,考察减重策略(营养、体力活动、手术或药物),包括GLP-1-RAs。在纳入的199项研究中,36项(18.1%)直接评估了GLP-1-RAs,其中14/36项(38.9%)报告了原始数据。证据严重偏向膝OA,髋部特异性数据有限。描述性分析显示研究地理分布狭窄,且对GLP-1-RAs的关注迅速增加;大多数涉及GLP-1-RAs的研究(29/36,80.6%)发表于2024年至2025年,且证据等级较低(19/36,52.8%为5级)。膝OA中的随机和队列数据表明,GLP-1-RAs与显著减重相关,并伴随疼痛/功能改善和进展至关节置换术减少。相比之下,髋OA证据稀少且关联较弱。GLP-1-RAs是管理合并肥胖的OA患者的一种有前景的辅助手段。在更多证据出现之前,GLP-1-RAs应被整合到有监督的多模式肌肉骨骼照护中,而非作为单独的减重药物使用。

基础研究 (1篇)

Cell metabolism IF 37.0 2026-9-22 PMID: 42772285
While osteoarthritis (OA) has traditionally been viewed as a localized joint disorder, systemic metabolic dysfunction is increasingly recognized as a key contributor to its pathogenesis. Here, we identify a liver-cartilage micronutrient axis in which hepatic dysfunction promotes OA through impaired selenium (Se) metabolism. Nationwide cohorts reveal elevated OA prevalence among individuals with liver disease. In murine models of acute and chronic liver injury and metabolic dysfunction-associated steatohepatitis (MASH), hepatic dysfunction disrupts the selenoprotein P (SELENOP)-ApoER2 axis, compromising Se delivery to cartilage. Mechanistically, hepatic stress reduces hepatocyte SELENOP output through convergent transcriptional repression and translational suppression via ribosome collision on selenocysteine (Sec)-rich SELENOP transcripts. The resulting cartilage selenoprotein deficiency promotes chondrocyte senescence, exacerbating OA. Inorganic Se supplementation bypasses impaired SELENOP-mediated Se delivery, restoring chondrocyte selenoproteins and alleviating OA, highlighting Se as a nutritionally modifiable factor. Our findings suggest preventive strategies against joint comorbidity in the growing population with metabolic liver disease.
中文摘要:尽管骨关节炎(OA)传统上被视为一种局部关节疾病,但全身性代谢功能障碍越来越被认为是其发病机制的重要促成因素。在此,我们鉴定出一条肝脏-软骨微量营养素轴,其中肝功能障碍通过硒(Se)代谢受损促进OA。全国性队列显示,肝病患者的OA患病率升高。在急性与慢性肝损伤以及代谢功能障碍相关脂肪性肝炎(MASH)的小鼠模型中,肝功能障碍破坏了硒蛋白P(SELENOP)-ApoER2轴,损害了硒向软骨的递送。在机制上,肝脏应激通过转录抑制以及对富含硒代半胱氨酸(Sec)的SELENOP转录本发生核糖体碰撞所导致的翻译抑制,二者共同降低肝细胞SELENOP的输出。由此导致的软骨硒蛋白缺乏促进软骨细胞衰老,从而加重OA。无机硒补充可绕过受损的SELENOP介导的硒递送,恢复软骨细胞硒蛋白并缓解OA,突出表明硒是一种可通过营养调节的因素。我们的研究结果提示,针对日益增多的代谢性肝病人群中的关节共病,可采取预防策略。

4感染/假体周围感染 (1篇)

基础研究 (1篇)

MedComm IF 14.1 2026-9-22 PMID: 42769368
Osteomyelitis (OM) is a severe inflammatory bone disease caused by pathogen invasion, representing a major challenge in orthopedic surgery. Staphylococcus aureus (S. aureus) is the predominant causative pathogen across all OM subtypes, and its increasing antibiotic resistance has further complicated clinical management. Despite advances in antibiotic therapy and surgical debridement, treatment failure and disease recurrence remain unacceptably high. Emerging evidence suggests that these poor outcomes are largely attributed to the intricate host-pathogen interplay within the bone microenvironment, yet the underlying immunological mechanisms remain incompletely understood. This review provides a comprehensive overview of the epidemiological characteristics, classification, clinical features, pathophysiology, and current diagnostic and therapeutic strategies for OM, with a particular focus on host immune dysregulation in disease initiation and chronicity, elucidating the mechanisms underlying immunosuppressive niche formation and persistent bone destruction. We further dissect the multifaceted immune evasion strategies employed by S. aureus, including biofilm formation, intracellular persistence, and abscess barrier construction, which collectively drive infection chronicity and progressive bone destruction. By synthesizing recent advances in osteoimmunology, this review identifies critical knowledge gaps and proposes potential targeted immunomodulatory interventions, offering promising avenues to overcome conventional treatment limitations.
中文摘要:骨髓炎(OM)是一种由病原体入侵引起的严重炎症性骨病,是骨科手术面临的一大挑战。金黄色葡萄球菌(S. aureus)是所有OM亚型中最主要的致病菌,其日益增加的抗生素耐药性使临床管理更加复杂。尽管抗生素治疗与手术清创不断进步,治疗失败与疾病复发率仍高得难以接受。新出现的证据提示,这些不良结局在很大程度上归因于骨微环境中错综复杂的宿主—病原体相互作用,但其潜在的免疫学机制仍未完全阐明。本综述全面概述了OM的流行病学特征、分类、临床特点、病理生理学以及当前的诊断与治疗策略,尤其关注宿主免疫失调在疾病发生与慢性化中的作用,阐明免疫抑制微环境形成与持续性骨破坏的机制。我们进一步剖析金黄色葡萄球菌所采用的多层面免疫逃逸策略,包括生物膜形成、胞内持续存在和脓肿屏障构建,这些策略共同驱动感染的慢性化与进行性骨破坏。通过综合骨免疫学的最新进展,本综述指出了关键的知识空白,并提出潜在的靶向免疫调节干预措施,为克服传统治疗局限提供了有前景的途径。

5骨折/创伤 (1篇)

基础研究 (1篇)

Signal transduction and targeted therapy IF 81.2 2026-9-22 PMID: 42768017
Fracture healing is a highly orchestrated regenerative process that depends on precise temporal and spatial coordination of immune, vascular, neural, and skeletal signaling programs. Disruption of these interconnected pathways, whether due to local injury factors, systemic disease, aging, or metabolic dysregulation, can impair repair and result in delayed union or nonunion. Understanding the molecular mechanisms that integrate inflammation resolution, progenitor cell fate decisions, neurovascular coupling, and endochondral bone formation is therefore essential for improving clinical outcomes. Recent advances show that fracture repair is governed by dynamic signaling networks linking immune cells, mesenchymal progenitors, endothelial and neural components, and the extracellular matrix. Key pathways regulating cytokine signaling, angiogenesis, mechanotransduction, hypoxia sensing, and osteochondral differentiation have emerged as critical determinants of healing efficiency and quality. These insights have reshaped therapeutic strategies, enabling the development of targeted interventions, including growth factor and anabolic therapies, immunomodulatory agents, cell- and gene-based approaches, extracellular vesicles, and biomaterial-assisted delivery systems. In this review, we synthesize current mechanistic understanding of both physiological and impaired fracture healing, with an emphasis on intercellular signaling and pathway-level regulation. We critically evaluate emerging targeted regenerative therapies in terms of their biological rationale, precision, and translational limitations, and discuss key barriers to clinical implementation. By shifting focus from descriptive pathology to actionable signaling frameworks, this review aims to guide the rational design of next-generation therapies for bone regeneration.
中文摘要:骨折愈合是一个高度协调的再生过程,依赖于免疫、血管、神经和骨骼信号程序在时间和空间上的精确协同。这些相互关联的通路一旦受到破坏,无论是由于局部损伤因素、全身性疾病、衰老还是代谢紊乱,都可能损害修复并导致延迟愈合或不愈合。因此,理解整合炎症消退、祖细胞命运决定、神经血管耦联和软骨内成骨等过程的分子机制,对于改善临床结局至关重要。近期进展表明,骨折修复受连接免疫细胞、间充质祖细胞、内皮和神经成分以及细胞外基质的动态信号网络调控。调节细胞因子信号、血管生成、机械转导、缺氧感知和骨软骨分化的关键通路,已成为决定愈合效率和质量的关键因素。这些认识重塑了治疗策略,使得靶向干预措施的开发成为可能,包括生长因子和合成代谢疗法、免疫调节剂、基于细胞和基因的方法、细胞外囊泡以及生物材料辅助递送系统。在这篇综述中,我们综合了当前对生理性和受损骨折愈合机制的理解,重点强调细胞间信号传导和通路层面的调控。我们批判性地评估了新兴靶向再生疗法在生物学依据、精确性和转化局限性方面的表现,并讨论了临床实施的关键障碍。通过将关注点从描述性病理学转向可操作的信号框架,本综述旨在指导下一代骨再生疗法的合理设计。

6关节置换 (1篇)

临床研究 (1篇)

British journal of sports medicine IF 15.5 2026-7-8 PMID: 42414085
Clinical guidelines consistently recommend low-impact physical activity (PA) for the management of hip or knee osteoarthritis (OA). This study aimed to determine the risk and mediators of joint replacement in people with hip or knee OA who participate in high-impact PA. We conducted a mediation analysis using data from the Good Life with osteoArthritis in Denmark (GLA:D) registry. Baseline PA was self-reported using the University of California, Los Angeles (UCLA) Activity Scale and categorised as high-impact, high-intensity, moderate-intensity or low-intensity. Outcomes were self-reported total hip replacement (THR) or total knee replacement (TKR) at 12 months. Candidate mediators measured at 3 months were joint pain intensity, functional capacity (30-second chair stand test) and fear of joint damage from PA. Among 5911 participants with hip OA (66.8 years, 69.5% women), 5.9% engaged in high-impact PA. Among 11 750 participants with knee OA (66.5 years, 72.7% women), 5.2% engaged in high-impact PA. High-impact PA was associated with 36-48% lower odds of THR and was not associated with altered risk of TKR. There was little evidence that pain intensity, functional capacity or fear of joint damage mediated these associations. However, a small indirect effect via functional capacity was observed, where a greater functional capacity was associated with a reduction in odds of TKR (OR 0.92, 95% CI 0.87 to 0.98). High-impact PA was associated with a substantially lower risk of THR, and did not increase TKR risk. Clinicians may consider recommending higher-impact activities for individuals with hip OA, and supporting continued participation in knee OA when symptoms, capacity and patient goals allow.
中文摘要:临床指南一致推荐低冲击性身体活动(PA)用于髋或膝骨关节炎(OA)的管理。本研究旨在确定参与高冲击性PA的髋或膝OA患者中关节置换的风险及中介因素。我们利用丹麦骨关节炎良好生活(GLA:D)登记处的数据进行中介分析。基线PA采用加州大学洛杉矶分校(UCLA)活动量表自报,并分为高冲击性、高强度、中等强度或低强度。结局为12个月时自报的全髋关节置换术(THR)或全膝关节置换术(TKR)。在3个月时测量的候选中介因素包括关节疼痛强度、功能能力(30秒坐立试验)和对PA导致关节损伤的恐惧。在5911名髋OA参与者(66.8岁,69.5%女性)中,5.9%参与高冲击性PA。在11750名膝OA参与者(66.5岁,72.7%女性)中,5.2%参与高冲击性PA。高冲击性PA与THR的比值降低36-48%相关,且与TKR风险改变无关。几乎没有证据表明疼痛强度、功能能力或对关节损伤的恐惧介导了这些关联。然而,观察到通过功能能力的小间接效应,即较高的功能能力与TKR比值降低相关(OR 0.92,95%CI 0.87至0.98)。高冲击性PA与THR风险显著降低相关,且未增加TKR风险。临床医生可考虑向髋OA个体推荐较高冲击性的活动,并在膝OA患者症状、能力和患者目标允许时支持其继续参与。

7运动医学 (1篇)

临床研究 (1篇)

British journal of sports medicine IF 15.5 2026-6-18 PMID: 42309785
Labral tears are common in young adults participating in high-impact physical activity. No longitudinal studies have investigated whether labral tears expedite cartilage loss. This longitudinal study investigated the association between labral tears and cartilage loss in young adults participating in high-impact physical activity. Study participants were high-impact athletes (soccer or Australian football) with and without hip and/or groin pain from the femoroacetabular impingement and hip osteoarthritis cohort study who underwent unenhanced 3T MRI at baseline and after 2-3 years. Labral tears and cartilage defects were scored semi-quantitatively. At baseline, labral tear presence (grade ≥2), subregion, number of subregions affected by labral tear, maximal labral score, labral sum score and presence of paralabral cysts were determined. A cartilage sum change score (difference between baseline and follow-up) was calculated for each hip (0-20). Negative binomial regression models were used to estimate if baseline labral tears were associated with cartilage loss, adjusting for sex, age, body mass index, alpha angle and baseline cartilage sum score. 173 (343 hips) participants (82% with hip and/or groin pain; 22% women) with a median age of 26 years were included. The median International Hip Outcome Tool-33 total score was 69 at baseline. Follow-up MRIs were collected at a median of 2.1 years after baseline. 150 (87%) participants were still participating in high-impact physical activity at follow-up. Weak-to-moderate strength associations were identified between cartilage sum change score and baseline anterior labral tears (adjusted incidence rate ratio (a)IRR 1.46; 95% CI 1.01 to 2.09), paralabral cysts (aIRR 1.38; 95% CI 1.02 to 1.86) and labral sum score (aIRR 1.05; 95% CI 1.00 to 1.09). Our findings suggest that acetabular labral tears contribute to cartilage loss in young adult athletes; however, the associations observed were modest, suggesting that additional factors contribute to cartilage loss in this population. Further research is required to inform preventative strategies aimed at reducing cartilage loss in athletes with labral tears.
中文摘要:髋臼盂唇撕裂在参与高冲击性体育活动的年轻成人中很常见。尚无纵向研究探讨盂唇撕裂是否会加速软骨丢失。本纵向研究探讨了参与高冲击性体育活动的年轻成人中盂唇撕裂与软骨丢失之间的关联。研究参与者为来自股骨髋臼撞击和髋骨关节炎队列研究的高冲击性运动员(足球或澳式橄榄球),伴或不伴髋部和/或腹股沟疼痛,他们在基线和2-3年后接受了非增强3T MRI检查。盂唇撕裂和软骨缺损采用半定量评分。基线时确定盂唇撕裂存在(分级≥2)、亚区、受盂唇撕裂影响的亚区数量、最大盂唇评分、盂唇总评分以及盂唇旁囊肿的存在。为每个髋关节计算软骨总变化评分(基线至随访的差值,0-20)。采用负二项回归模型评估基线盂唇撕裂是否与软骨丢失相关,并校正性别、年龄、体质指数、α角及基线软骨总评分。共纳入173名参与者(343个髋关节)(82%有髋部和/或腹股沟疼痛;22%为女性),中位年龄26岁。基线时国际髋关节结局工具-33总评分中位数为69。随访MRI在基线后中位2.1年时采集。随访时150名(87%)参与者仍在参与高冲击性体育活动。软骨总变化评分与基线前方盂唇撕裂(校正发病率比(a)IRR 1.46;95% CI 1.01至2.09)、盂唇旁囊肿(aIRR 1.38;95% CI 1.02至1.86)和盂唇总评分(aIRR 1.05;95% CI 1.00至1.09)之间存在弱至中等强度的关联。我们的研究结果提示,髋臼盂唇撕裂与年轻成人运动员的软骨丢失有关;然而,观察到的关联程度为中等,提示其他因素也导致该人群的软骨丢失。需要进一步研究以指导旨在减少盂唇撕裂运动员软骨丢失的预防策略。

8运动医学/关节镜 (1篇)

临床研究 (1篇)

British journal of sports medicine IF 15.5 2026-9-3 PMID: 42692805
To evaluate whether an 8-week smartphone-based multidisciplinary digital therapeutic (DTx) combining exercise and cognitive-behavioural therapy reduced usual knee pain at 8 weeks compared with education and exercise instruction in chronic patellofemoral pain (PFP). This multicentre, parallel-group randomised controlled trial included 216 participants with chronic PFP, defined as anterior or retropatellar pain lasting at least 3 months with activity-related provocation, recruited from orthopaedic outpatient clinics at 10 hospitals in the Republic of Korea. Participants were randomly assigned to the DTx group (MORA Cure PFP) or a control group receiving PFP-related education, one-time exercise instruction, printed materials and self-monitoring exercise diaries. The DTx intervention included personalised home-based exercises, weekly cognitive-behavioural sessions and self-reflective daily worksheets. Outcomes were assessed at baseline, 4, 8 and 12 weeks. The primary endpoint was usual pain at 8 weeks, measured using a 0-100 mm visual analogue scale (VAS). Secondary outcomes included worst pain, knee function (Anterior Knee Pain Scale; AKPS), health-related quality of life assessed using the 5-level EQ-5D version (EQ-5D-5L) and the EQ visual analogue scale (EQ VAS), and psychological distress (Patient Health Questionnaire-9 and Pain Catastrophizing Scale (PCS)). Longitudinal changes were analysed using linear mixed-effects models. For the primary endpoint, usual pain at week 8 favoured the DTx group (between-group mean difference -12.5 mm, 95% CI -17.1 to -7.8). Secondary outcomes at week 8 also favoured the DTx group, including worst pain (-10.7 mm, 95% CI -15.9 to -5.4), knee function (AKPS, 5.2 points, 95% CI 2.7 to 7.7), health-related quality of life (EQ VAS 10.7 points, 95% CI 7.1 to 14.4) and pain catastrophising (PCS, -1.8 points, 95% CI -3.3 to -0.3). Exercise adherence exceeded 80%, with no device-related or intervention-related serious adverse events reported. An 8-week smartphone-based multidisciplinary DTx programme reduced usual pain at 8 weeks compared with education and exercise instruction in patients with chronic PFP, with improvements in pain, knee function, health-related quality of life and psychological outcomes. These findings support the potential role of an integrated DTx package for delivering exercise and cognitive-behavioural support in PFP care. NCT06260865.
中文摘要:评估一种为期8周、基于智能手机、结合运动与认知行为疗法的多学科数字疗法(DTx)与教育和运动指导相比,能否减轻慢性髌股疼痛(PFP)患者8周时的通常膝关节疼痛。这项多中心、平行组随机对照试验纳入216例慢性PFP参与者,其定义为持续至少3个月、由活动诱发的前侧或髌后疼痛,参与者从韩国10家医院的骨科门诊招募。参与者被随机分配至DTx组(MORA Cure PFP)或对照组,对照组接受PFP相关教育、一次性运动指导、印刷材料和自我监测运动日记。DTx干预包括个性化居家运动、每周认知行为课程和自我反思每日工作表。结局在基线、4周、8周和12周时进行评估。主要终点为8周时的通常疼痛,采用0-100 mm视觉模拟量表(VAS)测量。次要结局包括最严重疼痛、膝关节功能(前膝痛量表;AKPS)、采用五水平EQ-5D版本(EQ-5D-5L)和EQ视觉模拟量表(EQ VAS)评估的健康相关生活质量,以及心理困扰(患者健康问卷-9和疼痛灾难化量表(PCS))。纵向变化采用线性混合效应模型分析。对于主要终点,第8周时的通常疼痛有利于DTx组(组间平均差-12.5 mm,95% CI -17.1至-7.8)。第8周时的次要结局也支持DTx组,包括最严重疼痛(-10.7 mm,95% CI -15.9至-5.4)、膝关节功能(AKPS,5.2分,95% CI 2.7至7.7)、健康相关生活质量(EQ VAS 10.7分,95% CI 7.1至14.4)和疼痛灾难化(PCS,-1.8分,95% CI -3.3至-0.3)。运动依从性超过80%,未报告器械相关或干预相关严重不良事件。与教育和运动指导相比,为期8周、基于智能手机的多学科DTx项目减轻了慢性PFP患者8周时的通常疼痛,并在疼痛、膝关节功能、健康相关生活质量和心理结局方面有所改善。这些发现支持整合式DTx方案在PFP照护中提供运动与认知行为支持的潜在作用。NCT06260865。